Universe Pharmaceuticals INC Accumulated Other Comprehensive Income
Universe Pharmaceuticals INC (UPC) had Accumulated Other Comprehensive Income of -$1.81 billion as of 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-01-29
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.81B.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.11B; Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed -$1.11M.
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.10M.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.37M; Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed -$2.41M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2025-09-30 | -$1.81B 20-F · filed 2026-01-29 | |
| 2024-09-30 | -$1.11B 20-F · filed 2026-01-29 | -$1.11M 20-F · filed 2025-04-29 |
| 2024-03-31 | -$2.10M 6-K · filed 2024-09-20 | |
| 2023-09-30 | -$2.37M 20-F · filed 2025-04-29 | -$2.41M 20-F · filed 2024-01-30 |
| 2023-03-31 | -$266.93K 6-K · filed 2023-08-31 | |
| 2022-09-30 | -$1.67M 20-F · filed 2024-01-30 | |
| 2022-03-31 | $2.58M 6-K · filed 2022-08-16 | |
| 2021-09-30 | $2.09M 20-F · filed 2023-02-10 | |
| 2020-09-30 | $895.39K 20-F · filed 2022-01-31 |